The TARGIT ( TARGeted Intraoperative Radiotherapy ) trial was designed to compare local recurrence and complication rates in breast cancer patients , prospectively randomised to either EBRT ( external beam whole breast radiotherapy ) or a single dose of IORT ( intraoperative radiotherapy ) .